Therapeutic Disorders: Differentiation Therapy

620 Words2 Pages

There are many diseases that are prevalent among adults, such as acute myeloid leukemia. Since the patients are usually old they often cannot receive the normal treatments such as chemotherapy because their old bodies cannot cope with the stresses that come with these aggressive treatments. To combat this problem researchers have been studying a milder treatment method called differentiation therapy to treat the adults who cannot handle the more invasive treatments (2). Differentiation therapy is a treatment in which chemical agents are used to induce undifferentiated cells, such as HL-60 cells, to differentiate into other more useful cells that can be used to fight off the disease. (3). HL-60 cells are a multipotent suspension cell line that …show more content…

Normally, retinoic acid plays roles in many bodily functions, such as proliferation, differentiation, embryogenesis, immunity, and metabolism. When treated with retinoic acid HL-60 cells produce granulocytes (3). Retinoic acid worked well both in vitro, during laboratory testing, and in vivo, during clinical trials (2). Another highly tested differentiation therapy agent is vitamin D3. Vitamin D3 assists the body with many functions such as immunity, cellular growth and regulating calcium and bone homeostasis. In addition, when HL-60 cells are treated with Vitamin D3 they differentiate into monocytes (3). When researchers tested vitamin D3 in vitro it worked well, however when they tested it in vivo it didn’t work very well. So to make vitamin D3 induce monocytic differentiation in vivo researchers have used vitamin D3 and retinoic acid together to produce a synergistic differentiation effect that allowed the cells to differentiate into monocytes in vivo …show more content…

In other words, would cells that are treated with both retinoic acid and vitamin D3 produce a useful amount of monocytic variation when compared to the amount of monocytic variation in cells treated with only vitamin D3? When vitamin D3 is added to HL-60 cells it binds to the vitamin D receptor, which then begins the process of signal transduction that leads to the cell differentiating into a monocyte (2). Some research has found that retinoic acid up regulates vitamin D receptor expression which allows more vitamin D3 to attach and induce monocytic differentiation (1). Because of the affect that retinoic acid has on the expression of the vitamin D receptor, one can predict that if HL-60 cells are treated with a combination of vitamin D3 and retinoic acid, there will be a greater induction of monocytes than if the cells were treated solely with vitamin D3. Other possibilities are that if HL-60 cells are treated with a combination of vitamin D3 and retinoic acid, there will be a lower induction of monocytes than if the cells were treated solely with vitamin D3 and if HL-60 cells are treated with a combination of vitamin D3 and retinoic acid, there will be no variation in monocytic induction when compared to cells treated with vitamin D3

More about Therapeutic Disorders: Differentiation Therapy

Open Document